Expertise in
2
conditions

Dr. Glynis Ablon

Dermatology
Lightning Cal Healthcare Services Inc.
1600 Rosecrans Ave, 
Manhattan Beach, CA 
Referral may be required
Before you request
Expertise in
2
conditions
Lightning Cal Healthcare Services Inc.
1600 Rosecrans Ave, 
Manhattan Beach, CA 

Overview

Glynis Ablon is a Dermatologist practicing medicine in Manhattan Beach, California.

Dr. Ablon is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Autosomal Recessive Hypotrichosis, Acne, Actinic Keratosis, and Bowen's Disease.

She is actively involved in clinical research, co-authoring 51 peer reviewed articles and participating in 6 clinical trials.

Specialties

Dermatology

Licenses

Dermatology in CA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Lightning Cal Healthcare Services Inc.
1600 Rosecrans Ave, Manhattan Beach, CA 90266

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Ability And Safety Of A Nutraceutical Supplement With Standardized Botanicals To Promote Hair Growth In Perimenopausal, Menopausal And Post-Menopausal Women With Self-Perceived Thinning Hair
A Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Ability And Safety Of A Nutraceutical Supplement With Standardized Botanicals To Promote Hair Growth In Perimenopausal, Menopausal And Post-Menopausal Women With Self-Perceived Thinning Hair
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Other, Dietary supplement
Study Phase: Not Applicable
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair
Enrollment Status: Completed
Publish Date: August 01, 2023
Intervention Type: Other, Dietary supplement
Study Phase: Not Applicable
A 6-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability and Safety of a Nutraceutical Supplement With Standardized Botanicals to Promote Hair Growth in Women With Self-Perceived Thinning Hair
A 6-Month, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Ability and Safety of a Nutraceutical Supplement With Standardized Botanicals to Promote Hair Growth in Women With Self-Perceived Thinning Hair
Enrollment Status: Completed
Publish Date: August 07, 2019
Intervention Type: Dietary supplement, Other
Study Phase: Not Applicable
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202 (Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of LIPO-202 (Salmeterol Xinafoate for Injection) for the Reduction of Submental Subcutaneous Fat
Enrollment Status: Completed
Publish Date: October 20, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

51 Total Publications

The Application of a Formulation Containing Hydroxypropyl Tetrahydropyrantriol and Niacinamide to Augment Anti-aging Benefits in a Double-blind, Randomized Nonablative Laser Treatment Study.
The Application of a Formulation Containing Hydroxypropyl Tetrahydropyrantriol and Niacinamide to Augment Anti-aging Benefits in a Double-blind, Randomized Nonablative Laser Treatment Study.
Journal: The Journal of clinical and aesthetic dermatology
Published: February 06, 2026
Similar Doctors
Expertise in
18
conditions
Expertise in
18
conditions
Referral may be required

Office

1450 San Pablo St Ste 2000, 
Los Angeles, CA 
 (15.2 miles away)
323-442-8500
Languages Spoken:
English
See accepted insurances
Offers Telehealth

April Armstrong is a Dermatologist practicing medicine in Los Angeles, California. Dr. Armstrong is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Psoriasis, Plaque Psoriasis, Atopic Dermatitis, and Acne.

Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required

Christiane Querfeld, M.D., PH.D.

1500 Duarte Rd, 
Duarte, CA 
 (28.4 miles away)
800-826-4673
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Christiane Querfeld is a Dermatologist practicing medicine in Duarte, California. Dr. Querfeld is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, and Sezary Syndrome.

Expertise in
6
conditions
Dr. Pearl Grimes
Dermatology
Expertise in
6
conditions
Dr. Pearl Grimes
Dermatology
Referral may be required

Office

5670 Wilshire Blvd Ste 650, 
Los Angeles, CA 
 (11.8 miles away)
323-467-4389
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Pearl Grimes is a Dermatologist practicing medicine in Los Angeles, California. Dr. Grimes is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Vitiligo, Hypomelanotic Disorder, Melasma, and Tinea Versicolor.

Frequently Asked Questions about Dr. Glynis Ablon

How do I make an appointment with Dr. Glynis Ablon?

You can book an appointment with Dr. Glynis Ablon by calling their office at 310-727-3376. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Glynis Ablon a top-rated expert for Autosomal Recessive Hypotrichosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Glynis Ablon is classified as an Distinguished expert for Autosomal Recessive Hypotrichosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Glynis Ablon specialize in?

While Dr. Glynis Ablon is a Dermatology, they have specific expertise in Autosomal Recessive Hypotrichosis, Acne, and Actinic Keratosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Glynis Ablon participate in research or clinical trials?

Yes. Dr. Glynis Ablon has published 51 articles and abstracts on conditions like Autosomal Recessive Hypotrichosis. You can view a list of Dr. Glynis Ablon's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Glynis Ablon accept my insurance?

Dr. Glynis Ablon accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 310-727-3376 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ablon's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile